# 3IA-poster-references

Sa√¢da-Bouzid, E., et al. "Hyperprogression during anti-PD-1/PD-L1 therapy in patients with recurrent and/or metastatic  head and neck squamous cell carcinoma." Annals of Oncology 28.7 (2017): 1605-1611.

Ferris, Robert L., et al. "Nivolumab for recurrent squamous-cell carcinoma of the head and neck." New England Journal of Medicine 375.19 (2016): 1856-1867.

Litchfield, Kevin, et al. "Meta-analysis of tumor-and T cell-intrinsic mechanisms of sensitization to checkpoint inhibition." Cell 184.3 (2021): 596-614.

Saint, A., and Van Obberghen-Schilling, E. (2021). The role of the tumor matrix environment in progression of head and neck cancer. Curr Opin Oncol 33, 168-174.
